Details for 2018783804
Up to date per 01.04.2026
Actions
Details for 2018783804
Deleted
European Patent
19.02.2020 A
15.05.2024 B1
11.04.2017
US
201762484128 P
28.09.2017
US
201762565044 P
C07D 209/82 20060101AFI20230512BHEP
Owner
GSNO Therapeutics, Inc.191 SE Vic King Rd. Shelton, WA 98584US
Representative
No representatives present
Inventor
PARIZA, Richard J.c/o SAJE Pharma LLC 1101 E. 33rd Street Third Floor Baltimore, Maryland 21218US
BRADLEY, Matthews O.c/o SAJE Pharma, LLC 164 Saddleback Trail Kalispell, MT 59901US